Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Endo Operations Limited currently manages 2 pending office actions within the Chemistry & Materials technology area. These matters are assigned to 2 distinct examiners and 2 distinct art units. This distribution indicates that the company's current workload is spread across 2 different administrative segments of the patent office.
The busiest examiner for the company is FAN, LYNN Y, who is responsible for 1 busiest examiner pending office action. This 1 action represents 1 of the 2 pending office actions identified in the portfolio. With 2 distinct examiners involved, the prosecution is not concentrated under 1 individual.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SASAN, ARADHANA | 1 | 64.5% | +26.2% |
| FAN, LYNN Y | 1 | 47.3% | +49.5% |
| MOSS, NATALIE M | 1 | 30.8% | +17.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17259784 | INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE | MOSS, NATALIE M | 34d |
| 17838636 | METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT | SASAN, ARADHANA | — |
| 17276507 | COMPOSITIONS AND METHODS FOR TREATING CELLULITE | FAN, LYNN Y | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1759 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17838636 | METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT | SASAN, ARADHANA | 1615 | Other | Non-Final OA | — | Pending | Jun 13, 2022 |
| 17276507 | COMPOSITIONS AND METHODS FOR TREATING CELLULITE | FAN, LYNN Y | 1759 | §103DP | Final Rejection | — | Pending | Mar 16, 2021 |
| 17259784 | INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE | MOSS, NATALIE M | 1653 | §103 | Non-Final OA | 34d | Pending | Jan 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial